این سایت در حال حاضر پشتیبانی نمی شود و امکان دارد داده های نشریات بروز نباشند
Iranian Journal of Basic Medical Sciences، جلد ۲۹، شماره ۳، صفحات ۳۲۲-۳۳۳
عنوان فارسی
چکیده فارسی مقاله
کلیدواژه‌های فارسی مقاله
عنوان انگلیسی A review on recent advances in lipid-based drug delivery systems for tuberculosis
چکیده انگلیسی مقاله Tuberculosis (TB) remains a global health challenge, as current therapeutic strategies, albeit effective, require prolonged treatment durations and strict patient adherence. This often results in treatment failure and contributes to the growing issue of antibiotic resistance. To address these challenges, extensive research has focused on innovative drug delivery systems to improve bioavailability, enhance site-specific targeting, and overcome the limitations of conventional TB treatment. In this review, we summarise recent advancements in solid lipid nanoparticles, nanostructured lipid carriers (NLCs), and functionalized lipid nanoparticles for TB treatment. A literature review was conducted focusing on the pathophysiology of TB,  in vitro and in vivo efficacy, and toxicity of lipid nanoparticles, and recent advancements in lipid nanoparticles for anti-TB drug delivery to the lungs. Studies demonstrated lipid nanoparticles significantly improve the solubility, stability, and targeted delivery of anti-TB drugs to infected macrophages. Rifampicin-loaded NLCs exhibited over 90% drug release sustained over 7 days and remained physically stable for up to 6 months. Mannose-functionalized NLCs showed around 70% macrophage uptake, doubling the rate of non-functionalized systems. In vivo studies on isoniazid-loaded SLNs reported a 3-fold increase in LD₅₀ and a> 26-fold enhancement in bioavailability. Mannosylated clofazimine-NLCs exhibited prolonged lung retention and significantly reduced hepatic and renal toxicity. These quantitative improvements highlight the potential of lipid-based systems to outperform conventional formulations in both efficacy and safety.These advancements demonstrate strong potential for clinical translation, offering a more effective and patient-friendly approach to TB treatment.
کلیدواژه‌های انگلیسی مقاله Antitubercular agents, Drug Delivery, Lipid nanoparticles, Liposomes, Nanoparticles, Tuberculosis
نویسندگان مقاله | Farah Natasya Zamani
Department of Pharmaceutical Technology, Faculty of Pharmacy, Universiti Malaya, 50603 Kuala Lumpur, Malaysia


| Najihah Mohd Hashim
Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Universiti Malaya, 50603 Kuala Lumpur, Malaysia|Centre for Natural Products Research and Drug Discovery, Universiti Malaya, 50603 Kuala Lumpur, Malaysia


| Rajesh Sreedharan Nair
School of Pharmacy, Faculty of Science and Engineering, University of Nottingham Malaysia, Jalan Broga, 43500 Semenyih, Selangor, Malaysia


| A’liyatur Rosyidah
Research Center of Vaccine and Drugs, Research Organization for Health, National Research and Innovation Agency (BRIN), Bogor, Indonesia


| Phuoc-Vinh Nguyen
University of Health Sciences, Vietnam National University, Ho Chi Minh City, Vietnam


| Sonny Kristianto
Department of Forensic Science, Postgraduate School, Airlangga University, Surabaya, 60286, Indonesia


| Intan Nurul Annisha Suhaili
Department of Pharmaceutical Technology, Faculty of Pharmacy, Universiti Malaya, 50603 Kuala Lumpur, Malaysia


| Nur Afifah Othman
Department of Pharmaceutical Technology, Faculty of Pharmacy, Universiti Malaya, 50603 Kuala Lumpur, Malaysia


| Sui Ling Janet Tan
Department of Pharmaceutical Technology, Faculty of Pharmacy, Universiti Malaya, 50603 Kuala Lumpur, Malaysia
نشانی اینترنتی https://ijbms.mums.ac.ir/article_27108.html
فایل مقاله فایلی برای مقاله ذخیره نشده است
کد مقاله (doi)
زبان مقاله منتشر شده en
موضوعات مقاله منتشر شده
نوع مقاله منتشر شده Review Article
برگشت به: صفحه اول پایگاه   |   نسخه مرتبط   |   نشریه مرتبط   |   فهرست نشریات